ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,379.08
-0.80%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Icosavax Inc (ICVX)

  7. Icosavax Inc (ICVX) Noticias

ICVX Icosavax Inc

15.31
0.00 (0.00%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Icosavax Inc ICVX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 15.31 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
15.31 15.31
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/3/202407:30EDGAR2Form 15-12G - Securities registration termination [Section..
21/2/202415:21EDGAR2Form SC 13D/A - General statement of acquisition of..
20/2/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
20/2/202418:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202418:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202418:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202418:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202418:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202418:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202418:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202407:46EDGAR2Form S-8 POS - Securities to be offered to employees in..
20/2/202407:43EDGAR2Form POS AM - Post-Effective amendments for registration..
20/2/202407:42EDGAR2Form 8-K - Current report
20/2/202407:32EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
02/2/202418:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202413:25PRNUSKuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to..
23/1/202417:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202408:04EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
12/1/202410:10PRNUSKuehn Law Encourages PXD, IMGN, HA and ICVX Investors to..
05/1/202418:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202415:52EDGAR2Form 144 - Report of proposed sale of securities
03/1/202413:57PRNUSKuehn Law Encourages EGLE, ICVX, RAIN, and AYX Investors to..
27/12/202307:55EDGAR2Form SC 14D9 - Solicitation, recommendation statements
22/12/202317:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202317:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202317:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202317:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202315:42EDGAR2Form 144 - Report of proposed sale of securities
21/12/202315:28EDGAR2Form 144 - Report of proposed sale of securities
20/12/202319:54EDGAR2Form 144 - Report of proposed sale of securities
20/12/202319:50EDGAR2Form 144 - Report of proposed sale of securities
20/12/202319:50EDGAR2Form 144 - Report of proposed sale of securities
20/12/202319:44EDGAR2Form 144 - Report of proposed sale of securities
20/12/202316:05EDGAR2Form SC14D9C - Written communication relating to third party..
20/12/202315:41EDGAR2Form 144 - Report of proposed sale of securities
15/12/202318:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202315:18EDGAR2Form SC14D9C - Written communication relating to third party..
13/12/202315:26EDGAR2Form 144 - Report of proposed sale of securities
12/12/202316:00EDGAR2Form SC14D9C - Written communication relating to third party..
12/12/202315:56EDGAR2Form SC14D9C - Written communication relating to third party..
12/12/202315:12EDGAR2Form 8-K - Current report
12/12/202305:25DJNIcosavax Shares Take Flight on Takeover by AstraZeneca
12/12/202302:02DJNAstraZeneca to Buy Icosavax for Up to $1.1 Billion -- Update
12/12/202301:47DJNAstraZeneca to Buy Icosavax for Up to $1.1 Billion
12/12/202301:05GLOBEIcosavax, Inc. Announces Agreement to be Acquired by..
12/12/202301:00GLOBEIcosavax Announces Positive Topline Interim Phase 2 Results..
14/11/202315:05GLOBEIcosavax Reports Third Quarter 2023 Financial Results and..
08/11/202307:00GLOBEIcosavax to Participate in the Jefferies London Healthcare..
31/10/202307:00GLOBEIcosavax to Participate in the Guggenheim Healthcare Talks..

Su Consulta Reciente

NASDAQ
ICVX
Icosavax
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados